Name: MAZE Balance Sheet - Maze Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

MAZE - Maze Therapeutics, Inc.

USD | NASDAQ | Healthcare

MAZE Balance Sheet - Maze Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23
Cash And Short Term Investments
Cash And Equivalents	198.8	189.2	316.8	264.5	294.4	196.8	149.6	175.1	30.0	-
Restricted Cash	-	-	-	-	-	-	-	-	-	-
Short Term Investments	153.6	152.7	67.2	-	-	-	-	-	-	-
Cash And Short Term Investments	352.4	341.9	383.9	264.5	294.4	196.8	149.6	175.1	30.0	-
Receivables
Accounts Receivable	20.0	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	7.4	7.8	7.4	6.6
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-
Current Liabilities
Accounts Payable	4.0	1.8	2.9	3.7	2.4	1.9	-	-	-	-
Short Term Debt	0.0	-	-	-
Non-Current Liabilities
Long Term Debt	38.8	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	17.6	18.5	19.4
Common Equity
Common Stock	0.1	0.0	0.0	0.0	0.0	0.0	-	-	-	-
Additional Paid In Capital	855.5	844.4	834.3	687.1
Supplementary Data
Total Debt	38.8	-	-	-	-	-	-	-	-	-
Net debt	(313.5)	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023
Cash And Short Term Investments
Cash And Equivalents	189.2	196.8	-
Restricted Cash	-	-	-
Short Term Investments	152.7	-	-
Cash And Short Term Investments	341.9	196.8	-
Receivables
Accounts Receivable	-	-	-
Current Assets
Inventory	-	-	-
Prepaid Expenses	7.8	4.9	-
Other Current Assets	-	-	-
Assets Held For Sale	-
Non-Current Assets
Property, Plant & Equipment Gross	24.3	23.5	-
Accumulated Depreciation	19.2	16.9	-
Property,Plant & Equipment Net	5.0	6.7	-
Long Term Investments
Current Liabilities
Accounts Payable	1.8	1.9	-
Short Term Debt	-	-	-
Deferred Revenue Current	-	-	-
Operating Lease Liabilities Current
Non-Current Liabilities
Long Term Debt	-	-	-
Operating Lease Liabilities Non-Current	18.5	22.0	-
Deferred Revenue Non-Current	-	-	-
Deferred Tax Liabilities
Common Equity
Common Stock	0.0	0.0	-
Additional Paid In Capital	844.4	47.2	-
Retained Earnings	(489.5)	(358.4)	-
Accumulated Other Comprehensive Income
Supplementary Data
Total Debt	-	-	-
Net debt	-	-	-
Working Capital	327.2	181.0	-
Book Value	355.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)